The People’s Republic of China International Science and Technology Cooperation Award was presented to The University of Texas MD Anderson Cancer Center at a ceremony held on January 9 at Beijing in the Great Hall of the People.
Among the attendees were the Chinese President Xi Jinping, the Vice Premier Liu Yandong and the Premier Li Keqiang. According to MD Anderson’s news release, this event is “recognized by MD Anderson’s many international ties to sister institutions in China with which it shares collaborative programs in training, education and patient care.”
This award is granted through the Chinese State Council to science and technology engineers and managers, foreign scientists or organizations that have, according to the news release, “made important contributions to China’s bilateral or multilateral scientific and technological cooperation.”
Oliver Bogler, vice president for academic affairs, accepted the award on behalf of MD Anderson. Additionally, Ta-Jen Liu, the project director of global academic programs also attended the ceremony.
“Cancer is a significant challenge worldwide. Every country has a unique spectrum of cancers, influenced by factors such as population and environment, and collaborating to study these cancers is critical to making progress. China in particular offers tremendous opportunities for saving lives through joint cancer research with top scientists and the government’s commitment to fighting cancer,” explained Bogler.
Bogler further noted that collaborations with Chinese partners have been crucial and productive in areas like lung and liver cancer treatment, cancer screening and cooperation in clinical trials and basic research studies. “It is increasingly important to share information and create ties that help all nations in our collective fight against cancer. (…) Receiving this coveted award from China is an honor for our institution and one that speaks to our commitment to collaboration, here at home and across the globe,” Dr. Ron DePinho, MD Anderson’s president, added in the news release.
The MD Anderson nomination for this award originated from its sister institution, the Sun Yat-sen University Cancer Center in Guangzhou.
The Chinese Academy of Medical Sciences Cancer Institute and Hospital, Beijing; Tianjin Medical University Cancer Institute and Hospital; Fudan University Shanghai Cancer Center; and the Sir YK Pao Centre for Cancer, Chinese University of Hong Kong are also MD Anderson’s sister institutions, according to the news release.